Amanote Research
Register
Sign In
Phase II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
The Internet Journal of Oncology
doi 10.5580/10e2
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2007
Authors
Unknown
Publisher
Internet Scientific Publishers, LLC
Related search
A Phase II, Randomized, Multicenter Study Evaluating the Combination of Lapatinib and Vinorelbine in Women With ErbB2 Overexpressing Metastatic Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
A Phase II Study of Carboplatin in Advanced or Metastatic Stomach Cancer
European Journal of Cancer and Clinical Oncology
A Phase II, Multicentre, UK Study of Vinorelbine in Advanced Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer
Breast Care
Surgery
Oncology
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Oncologist
Cancer Research
Medicine
Oncology
Metastatic Breast Cancer: Focus on Capecitabine
Clinical Medicine Reviews in Oncology
A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients With Metastatic Esophageal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I Dose-Finding Study of Eribulin and Capecitabine for Metastatic Breast Cancer: JBCRG-18 Cape Study
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
